Skip to Content
Merck
  • Cancer chemoprevention by citrus pulp and juices containing high amounts of β-cryptoxanthin and hesperidin.

Cancer chemoprevention by citrus pulp and juices containing high amounts of β-cryptoxanthin and hesperidin.

Journal of biomedicine & biotechnology (2011-12-17)
Takuji Tanaka, Takahiro Tanaka, Mayu Tanaka, Toshiya Kuno
ABSTRACT

β-Cryptoxanthin, a carotenoid, and hesperidin, a flavonoid, possess inhibitory effects on carcinogenesis in several tissues. We recently have prepared a pulp (CHRP) and citrus juices (MJ2 and MJ5) from a satsuma mandarin (Citrus unshiu Mar.) juice (MJ). They contain high amounts of β-cryptoxanthin and hesperidin. We have demonstrated that CHRP and/or MJs inhibit chemically induced rat colon, rat tongue, and mouse lung tumorigenesis. Gavage with CHRP resulted in an increase of activities of detoxifying enzymes in the liver, colon, and tongue rats'. CHRP and MJs were also able to suppress the expression of proinflammatory cytokines and inflammatory enzymes in the target tissues. This paper describes the findings of our in vivo preclinical experiments to develop a strategy for cancer chemoprevention of colon, tongue, and lung neoplasms by use of CHRP and MJs.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Hesperidin, ≥80% (HPLC)
Supelco
Hesperidin, analytical standard
Sigma-Aldrich
β-Cryptoxanthin, ≥97% (TLC)
Hesperidin, European Pharmacopoeia (EP) Reference Standard